Profusa (PFSA) Total Non-Current Liabilities (2021 - 2026)
Profusa (PFSA) reported Total Non-Current Liabilities of $17.6 million for Q1 2026, up 23.67% on a YoY basis from $14.3 million in Q1 2025, and down 2.53% quarter-over-quarter from $18.1 million in Q4 2025.
Profusa (PFSA) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
Profusa has reported Total Non-Current Liabilities for 6 years, with the latest figure at $17.6 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 23.67% year-over-year to $17.6 million; the trailing twelve-month figure through Mar 2026 stood at $17.6 million (up 23.67% YoY), and the FY2025 full-year result was $18.1 million, down 67.03% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $17.6 million, down from $18.1 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $54.9 million in Q4 2024, with the low at -$18.8 million in Q3 2025.
- Historically, Total Non-Current Liabilities has averaged $7.8 million across 5 years, with a median of $3.6 million in 2024.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities surged 3889.45% — and 2025, when it slumped 627.3%.
- Profusa's Total Non-Current Liabilities stood at $1.4 million in 2022, then surged by 257.37% to $5.1 million in 2023, then surged by 979.2% to $54.9 million in 2024, then sank by 67.03% to $18.1 million in 2025, then dropped by 2.53% to $17.6 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $17.6 million (Q1 2026), $18.1 million (Q4 2025), and -$18.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Profusa | 1.37 Mn | 1.37 Mn | - | 17.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.64 Mn |
| Dec 31, 2025 | 18.10 Mn |
| Sep 30, 2025 | -18.85 Mn |
| Jun 30, 2025 | 16.18 Mn |
| Mar 31, 2025 | 14.26 Mn |
| Dec 31, 2024 | 54.90 Mn |
| Sep 30, 2024 | 3.57 Mn |
| Jun 30, 2024 | 4.71 Mn |
| Mar 31, 2024 | 4.33 Mn |
| Dec 31, 2023 | 5.09 Mn |
| Sep 30, 2023 | 3.37 Mn |
| Jun 30, 2023 | 3.38 Mn |
| Mar 31, 2023 | 3.41 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 400,282.00 |
| Jun 30, 2022 | 160,243.00 |
| Mar 31, 2022 | 85,588.00 |
| Dec 31, 2021 | 4.24 Mn |